Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Segovia

Showing results (111-120 of 220) with videos related to

Pageof 22
Sort By:
Cardiovascular Diagnosis and Therapy|September 16, 2021
Checkpoint inhibitor-induced fulminant myocarditis, complete atrioventricular block and myasthenia gravis-a case reportAntonio Portolés Hernández, Mariola Blanco Clemente, Daniel Escribano García, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 26, 2014
Report from a consensus conference on primary graft dysfunction after cardiac transplantationJon Kobashigawa, Andreas Zuckermann, Peter Macdonald, et al.
Internal Medicine Journal|April 3, 2020
Prognostic impact of hyponatraemia and hypernatraemia at admission and discharge in heart failure patients with preserved, mid-range and reduced ejection fractionLourdes Vicent, Jesús Alvarez-Garcia, José Ramón Gonzalez-Juanatey, et al.
European Heart Journal|August 9, 2011
Mitochondrial haplogroups associated with end-stage heart failure and coronary allograft vasculopathy in heart transplant patientsM Esther Gallardo, Pablo García-Pavía, Raquel Chamorro, et al.
Internal Medicine Journal|March 20, 2019
Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fractionLourdes Vicent, Juan Cinca, Rafael Vazquez-García, et al.
Journal of Internal Medicine|February 20, 2022
Management and prognosis of HIV-associated pulmonary arterial hypertension: 20 Years of evidence from the REHAP registryMaría Lázaro Salvador, Luis Rodríguez-Padial, Clara Soto Abánades, et al.
Journal of Clinical Medicine|April 30, 2021
Ischemic Etiology and Prognosis in Men and Women with Acute Heart FailureLourdes Vicent, Jose Guerra, Rafael Vazquez-García, et al.
Revista Espanola De Cardiologia (English Ed.)|January 4, 2020
Economic analysis of intermittent intravenous outpatient treatment with levosimendan in advanced heart failure in SpainNicolás Manito Lorite, Darío Rubio-Rodríguez, José González Costello, et al.
Circulation. Heart Failure|August 20, 2021
Early Preventive Treatment With Enalapril Improves Cardiac Function and Delays Mortality in Mice With Arrhythmogenic Right Ventricular Cardiomyopathy Type 5Fernando Domínguez, Laura Lalaguna, Marina López-Olañeta, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|December 4, 2020
Should We Expand Cardiac Response Criteria in Patients with Light Chain Cardiac Amyloidosis?Jorge V López-Ibor, Isabel Krsnik, Manuel Gómez-Bueno, et al.
Pageof 22

Showing results (111-120 of 220) with videos related to

Sort By:
Pageof 22
Cardiovascular Diagnosis and Therapy|September 16, 2021
Checkpoint inhibitor-induced fulminant myocarditis, complete atrioventricular block and myasthenia gravis-a case reportAntonio Portolés Hernández, Mariola Blanco Clemente, Daniel Escribano García, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 26, 2014
Report from a consensus conference on primary graft dysfunction after cardiac transplantationJon Kobashigawa, Andreas Zuckermann, Peter Macdonald, et al.
Internal Medicine Journal|April 3, 2020
Prognostic impact of hyponatraemia and hypernatraemia at admission and discharge in heart failure patients with preserved, mid-range and reduced ejection fractionLourdes Vicent, Jesús Alvarez-Garcia, José Ramón Gonzalez-Juanatey, et al.
European Heart Journal|August 9, 2011
Mitochondrial haplogroups associated with end-stage heart failure and coronary allograft vasculopathy in heart transplant patientsM Esther Gallardo, Pablo García-Pavía, Raquel Chamorro, et al.
Internal Medicine Journal|March 20, 2019
Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fractionLourdes Vicent, Juan Cinca, Rafael Vazquez-García, et al.
Journal of Internal Medicine|February 20, 2022
Management and prognosis of HIV-associated pulmonary arterial hypertension: 20 Years of evidence from the REHAP registryMaría Lázaro Salvador, Luis Rodríguez-Padial, Clara Soto Abánades, et al.
Journal of Clinical Medicine|April 30, 2021
Ischemic Etiology and Prognosis in Men and Women with Acute Heart FailureLourdes Vicent, Jose Guerra, Rafael Vazquez-García, et al.
Revista Espanola De Cardiologia (English Ed.)|January 4, 2020
Economic analysis of intermittent intravenous outpatient treatment with levosimendan in advanced heart failure in SpainNicolás Manito Lorite, Darío Rubio-Rodríguez, José González Costello, et al.
Circulation. Heart Failure|August 20, 2021
Early Preventive Treatment With Enalapril Improves Cardiac Function and Delays Mortality in Mice With Arrhythmogenic Right Ventricular Cardiomyopathy Type 5Fernando Domínguez, Laura Lalaguna, Marina López-Olañeta, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|December 4, 2020
Should We Expand Cardiac Response Criteria in Patients with Light Chain Cardiac Amyloidosis?Jorge V López-Ibor, Isabel Krsnik, Manuel Gómez-Bueno, et al.
Pageof 22